Percutaneous posterior tibial nerve stimulation for Voiding Dysfunction

Pregnancy and childbirth, pelvic surgery and some medication (diuretics and anticholinergic), obesity, some neurological disease (Multiple-sclerosis, spinal cord injury, diabetes) are associated with urge incontinence as the long-held clinical impression confirmed. The aim of this study was to evaluate the efficacy of percutaneous tibial nerve stimulation (PTNS) for the treatment of complaints related to overactive bladder syndrome: urinary urgency, urinary frequency, urge incontinence (UI), non- obstructive urinary retention.

Percutaneous tibial nerve stimulation for the treatment of overactive bladder: treatment interval frequency.

The Overactive Bladder Innovative Therapy (OrBIT) Trial Phase 2 demonstrated the long term effectiveness of percutaneous tibial nerve stimulation (PTNS) for the treatment of overactive bladder (OAB). Symptom improvements after 12-weekly PTNS treatments were sustained throughout 12 months of therapy. The objective of this study was to evaluate the treatment interval frequency necessary to maintain efficacy.

Poster, Society for Urodynamics and Female Urology, St. Petersburg, FL.